Inventia Healthcare recalls blood pressure medication due to dissolution issues

Blood pressure medication recall overview:

• Who: Inventia Healthcare Limited is recalling 11,460 bottles of Chlorthalidone tablets.
• Why: The recall is due to the tablets failing to dissolve properly, potentially affecting drug efficacy.
• Where: This recall is effective nationwide in the United States.

Inventia Healthcare Limited has initiated a voluntary recall of more than 11,000 bottles of its blood pressure medication, Chlorthalidone, due to concerns over the drug’s dissolution specifications.

The Chlorthalidone recall, which began on June 5, affects specific batches of the 25 mg tablets, which may not dissolve properly, potentially reducing their effectiveness.

The U.S. Food and Drug Administration (FDA) classified this blood pressure medication recall as a Class II, indicating that the use of the affected product could lead to temporary or medically reversible adverse health consequences, although the probability of serious health issues is considered remote.

The affected Chlorthalidone tablets were manufactured by Inventia Healthcare in India and distributed by Rising Pharma Holdings in New Jersey. They are available in bottles of 100 or 1000 tablets, with batch numbers RISA24001 and RISB24002, respectively, and an expiration date of April 2027.

Chlorthalidone tablets failed dissolution tests

The recall notice highlights that the dissolution testing failure could mean the drug has reduced efficacy, which is crucial for patients relying on it for managing high blood pressure and related conditions.

Dissolution testing is a standard procedure in the pharmaceutical industry to ensure that drugs dissolve properly in the body, ensuring their effectiveness.

The FDA has not issued a press release regarding the Chlorthalidone blood pressure medication recall, but it has been documented in an enforcement report. Neither Inventia Healthcare nor the FDA has provided specific guidance on what consumers should do with the recalled medication.

Consumers seeking more information about the recall can visit the FDA drug recall page.

There are no reports of illness or injury related to the recall so far. Inventia is not currently facing legal action over the recall, but Top Class Actions follows recalls closely as they sometimes lead to class action lawsuits.

Also in June, Pfizer reached an agreement in principle to resolve thousands of lawsuits alleging the company failed to warn consumers about an alleged link between its Depo-Provera contraceptive injection and meningioma brain tumors.

Are you affected by this blood pressure medication recall? Let us know in the comments.

Read About More Class Action Lawsuits & Class Action Settlements:

• Consumers sue Target over recalled Up & Up baby wipes and alleged refund failures
• Nissan class action alleges Rogue Sport defective radiator fans cause overheating
• Master Lock class action claims 140 line of padlocks are not pick-resistant
• Meta social media addiction lawsuits cleared for August bellwether trial